These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6481982)
1. [Parkinson's disease and neurotransmitters]. Narabayashi H Nihon Rinsho; 1984 Apr; 42(4):869-74. PubMed ID: 6481982 [No Abstract] [Full Text] [Related]
2. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
3. Levodopa for the treatment of Parkinson's disease. Lewitt PA N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127 [No Abstract] [Full Text] [Related]
5. Decreased dopamine in the retinas of patients with Parkinson's disease. Harnois C; Di Paolo T Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2473-5. PubMed ID: 2243012 [TBL] [Abstract][Full Text] [Related]
6. [Striatal dopamine availability in Parkinson's disease--with reference to the wearing-off phenomenon]. Indo T Rinsho Shinkeigaku; 1984 Oct; 24(10):1008-16. PubMed ID: 6518691 [No Abstract] [Full Text] [Related]
9. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. Montastruc JL; Schmitt L; Bagheri H Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874 [TBL] [Abstract][Full Text] [Related]
10. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable. Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663 [No Abstract] [Full Text] [Related]
11. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder. Beucke JC; Uhl I; Plotkin M; Winter C; Assion HJ; Endrass T; Amthauer H; Kupsch A; Juckel G World J Biol Psychiatry; 2010 Sep; 11(6):781-7. PubMed ID: 20586535 [TBL] [Abstract][Full Text] [Related]
12. Levodopa in the treatment of Parkinson's disease. Lloyd KG Prim Care; 1977 Sep; 4(3):541-60. PubMed ID: 264229 [TBL] [Abstract][Full Text] [Related]
16. [Parkinson's disease]. de Saxce H Rev Infirm; 1979 Jan; 29(1):50-7. PubMed ID: 252780 [No Abstract] [Full Text] [Related]
17. New perspectives in the treatment of Parkinson's disease. LeWitt PA Clin Neuropharmacol; 1986; 9 Suppl 1():S37-54. PubMed ID: 3085929 [No Abstract] [Full Text] [Related]
18. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease. Yokochi M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038 [TBL] [Abstract][Full Text] [Related]
19. Protein intake and treatment of Parkinson's disease with levodopa. Mena I; Cotzias GC N Engl J Med; 1975 Jan; 292(4):181-4. PubMed ID: 1109209 [No Abstract] [Full Text] [Related]
20. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]